UK government targets manufacturing as it eyes £41bn life science sector growth
With the aim of being the largest life sector by 2035 behind only the US and China, the UK government is ramping up commercialisation.
Sino Biopharma spends $951m to acquire China-based LaNova Medicines
Navamedic completes dne pharma acquisition
Acumen and JCR partner on brain delivery therapy for Alzheimer’s
Otsuka to acquire Cantargia’s CAN10 for autoimmune diseases
Health Canada extends Evkeeza approval for children with HoFH
Analysis
View More
Themes
View MoreFive lessons from biopharma companies’ data transformation journeys
A sales rep looking up a healthcare professional's (HCP) contact details finds three records, each with conflicting information. At the same time, leadership struggles to generate accurate global reports due...
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
AI in drug discovery: from hypothetical to reality
Lisata collaborates with GATC Health on drug development
Juvenescence enhances AI drug discovery with Ro5 acquisition
Pharma’s AI prospects get nudged into the future with EU’s AI act